Differences in walking patterns could predict type of cognitive decline in older adults

St. Joseph's patients were among the participants in clinical trials that are helping researchers understand the link between impaired gait and dementia

Canadian researchers are the first to study how patterns in the way older adults walk could more accurately diagnose different types of dementia and identify Alzheimer’s disease. 

man walking along a path marked with lines every foot, in a researcher's clinic room
Patterns in the way older adults walk could more accurately diagnose different types of dementia.

A new study by a Canadian research team, led by London researchers from Lawson Health Research Institute and Western University, evaluated the walking patterns and brain function of 500 participants currently enrolled in clinical trials. Their findings are published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.  

“We have longstanding evidence showing that cognitive problems, such as poor memory and executive dysfunction, can be predictors of dementia. Now, we’re seeing that motor performance, specifically the way you walk, can help diagnose different types of neurodegenerative conditions,” says Dr. Manuel Montero-Odasso, Scientist at Lawson and Professor at Western’s Schulich School of Medicine & Dentistry.  

Dr. Manuel Montero-Odasso wearing a suit and tie, standing in front of a wall of books
Dr. Manuel Montero-Odasso is leading the Mobility, Exercise and Cognition (MEC) team in London.

Dr. Montero-Odasso is world renowned for his research on the relationship between mobility and cognitive decline in aging. Leading the Mobility, Exercise and Cognition (MEC) team in London, he is pioneering novel diagnostic approaches and treatments to prevent and combat early dementia. Dr. Montero-Odasso is also co-lead of the Mobility, Exercise and Cognition Team at CCNA, a team composed of 22 researchers and 6 trainees. 

This study compared gait impairments across the cognitive spectrum, including people with Subjective Cognitive Impairment, Parkinson’s Disease, Mild Cognitive Impairment, Alzheimer’s disease, Lewy body dementia and Frontotemporal dementia, as well as cognitively healthy controls. The study used data from the COMPASS-ND Cohort and from the Gait and Brain Study Cohort. 

Read more from this article on the Lawson Health Research Institute website.

Back to all Stories